MannKind (MNKD)
(Delayed Data from NSDQ)
$4.82 USD
+0.08 (1.69%)
Updated May 22, 2024 04:00 PM ET
After-Market: $4.82 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Brokerage Reports
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 221 - 228 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
A good day for MannKind: done with FDA meeting, successful Type 1 diabetes Phase III trial
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
It''s a CRL but no need for new studies, no safety issues raised: bear story loses a lot of its punch.
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S